FROM EARLY REPLICONS TO PRESENT-DAY RNA VIRUSES {#cesec1}
===============================================

The quasispecies theory of molecular evolution was first proposed to describe the error-prone replication, self-organization, and adaptability of primitive replicons such as those thought to have populated the earth some 4000 million years before the present ([@bib65], [@bib66]; [@bib70]; see Chapter 1). Quasispecies was formulated initially as a deterministic theory involving mutant distributions of infinite population size in equilibrium. Extensions and generalizations to ensembles of genomes of finite population size replicating in changing environments have been developed ([@bib67]; [@bib234], [@bib235]; [@bib204]). Virologists use the term "viral quasispecies" to mean complex distributions of non-identical but closely related viral genomes subjected to genetic variation, competition and selection, and which act as a unit of selection (reviewed in different chapters of [@bib48]). More simple and general, a quasispecies has been defined as a population of similar genomes ([@bib171]). Quasispecies dynamics is most clearly manifested in systems such as RNA viruses that display short duplication times, generally high fecundity, and error-prone replication, traits that have been maintained despite a probable ancient origin of most extant RNA viruses in coevolution with a cellular world. Increasing numbers of careful analyses of viral populations have supported quasispecies dynamics for animal and plant RNA viruses (for recent examples see [@bib93]; [@bib249] and references included in these articles; see also other chapters of this book).

As discussed by Villarreal in Chapter 21, there are two main hypotheses regarding the origin of RNA viruses and other RNA genetic elements: that they are remnants of an ancient RNA world, or that they are modern derivatives of cells, originated in cellular RNAs that acquired autonomous replication. Viroids and other subviral RNA replicons may be direct descendants of early RNA (or RNA-like) replicons that preceded an organized cellular world ([@bib198]) (Chapter 2). Cells and viruses share a considerable number of essential functional domains or modules: polymerases, proteases, enzymes involved in nucleotide and nucleic acid metabolism, etc. However, on the basis of key proteins involved in viral replication, that are absent in cells, and also based on the evidence of extensive genetic exchange between diverse viruses, the concept of an ancient virus world has been proposed ([@bib129]). A primordial pool of genetic elements could have been the ancestor of viral and cellular genes. Cells and viruses share a ubiquitous ability to modify, lose, or acquire new genes or gene segments through genomic rearrangements, insertions, deletions, and other recombination events. Shuffling of functional modules among cells, viruses, and other replicons (plasmids, episomes, transposons, retrotransposons) is probably a frequent occurrence through fusion, transfection, conjugation, and other types of horizontal gene transfers ([@bib17]; [@bib108]; [@bib250]; [@bib41]; [@bib109]; [@bib21]). Sequence comparisons strongly suggest that all extant viruses have deep, ancient evolutionary roots ([@bib98]; [@bib227]) (Chapter 21).

ERROR-PRONE REPLICATION NECESSITATES LIMITED GENETIC COMPLEXITY TO PROTECT AGAINST ERROR CATASTROPHE {#cesec2}
====================================================================================================

One of the critical features that distinguishes cells from viruses is the difference in the complexity of their genetic material, even after accounting for repeated DNA in animal and plant cells. Complexity in this case means the amount of genetic information encoded in their genetic material. A typical mammalian cell includes a number of chromosomes amounting to a total of about 3 × 10^9^ base pairs (bp) of DNA. The chromosomal DNA of *Escherichia coli* has a complexity of about 4 × 10^6^bp. In contrast, RNA viruses have genomes in the range of 3.0 × 10^3^ to 3.2 × 10^4^ nucleotides. Point mutation rates for eukaryotic cells have been estimated to be in the range of 10^−10^--10^−11^ substitutions per nucleotide (s/nt), while for bacterial cells, values may reach up to 10^−9^ s/nt ([@bib82]). Mutation rates for a number of genomic sites of RNA viruses, determined using both genetic and biochemical procedures, are in the range of 10^−3^--10^−5^s/nt ([@bib57]; [@bib59]; [@bib58]; [@bib49]) (Chapter 7). Despite mutation rates varying with a number of environmental parameters, the above values mean that, in the process of RNA replication or retrotranscription, each progeny genomic molecule of about 10kb will contain on average 0.1 to several mutations. These determinations of mutation rates and frequencies suggest that even the viral progeny of a single infected cell will be genetically heterogeneous ([@bib53]; [@bib110]; [@bib222], [@bib223]; [@bib48], [@bib49]; see also other chapters of this book).

Penetration into the composition of mutant spectra, either by determining the nucleotide sequence of many clones from the same population, or by other "diving" strategies, has quantitated large genotypic and phenotypic diversity within mutant spectra ([@bib61], [@bib62]; [@bib162]; [@bib144]; [@bib180]; [@bib191]; [@bib241]; [@bib79]; [@bib89]; [@bib93]; [@bib249]). Diversity can extend to multiple mutant and recombinant genomes within an infected organ, and even within a single infected cell. Diversity of genetic forms is a prerequisite for evolution, including the major transitions undergone by our biosphere ([@bib66]; [@bib150]). RNA viruses have an exhuberant diversity to offer as a substrate for evolution. A virus population, by virtue of consisting of dynamic mutant spectra rather than a defined genomic sequence, has the potential to adapt readily to a range of environments.

One of the predictions of quasispecies dynamics of RNA viruses is the existence of an error threshold, defined as an average copying fidelity value at which a transition between an organized mutant spectrum and sequences lacking information contents occurs (reviewed in [@bib70]; [@bib69]; [@bib16]; [@bib171]; Chapters 1 and 9). This transition has been coined "entry into error catastrophe," a term first used by L. Orgel to describe errors during protein synthesis that could contribute to a collapse of cellular regulatory networks in the process of aging ([@bib175]). Both, the concept expressed by Orgel and the one applied to genetic information of viruses address deterioration of meaningful information with a biological consequence, due to errors in an informational macromolecule. The error threshold relationship establishes a limitation for the maximum complexity of genetic information that can be stably maintained by a replicon displaying a given copying accuracy (Chapter 1). Theoretical calculations of the range of mutation rates that should be compatible with maintenance of the information carried by the simple RNA bacteriophages were compatible with the mutation rates and frequencies found experimentally (compare [@bib13]; [@bib52], [@bib53], with [@bib70]; [@bib69]). In addition to intrinsic copying fidelity levels of viral polymerases, other biochemical features of virus replication may have evolved to preserve a minimal replication accuracy. It has been hypothesized that the "rule of six" (genome of polyhexameric length) in Mononegavirales that edit their phosphoprotein mRNA, may have evolved to prevent the negative effects of illegitimate editing that could result in error catastrophe ([@bib128]). Some biological systems exploit enhanced mutagenesis as a defense mechanism against invading molecular parasites. A mechanism known as "repeat-induced point mutations (RIP)" operates in some filamentous fungi such as *Neurospora crassa* resulting in the production of mutations in repeat DNA copies that penetrate into the cells ([@bib21]; [@bib84]). Also, the APOBEC3 family of cytidine deaminases are innate immunity factors that induce hypermutation in retroviral DNA. Such activities can be regarded as a form of natural "error catastrophe" against retroviral genomes (see Chapter 8). Thus, a mutagenesis-based antiviral approach to drive virus to extinction has a parallel in natural mechanims which have contributed to the survival of organisms in the face of perturbing molecular parasites.

Increased genetic complexity as is embodied in cells required a correspondingly higher copying accuracy of the genetic material. This appears to have been accomplished with a number of pathways for post-replicative repair mechanisms as well as with the acquisition of a 3′-5′ proofreading-repair exonuclease activity by most cellular DNA polymerases ([@bib97]). No evidence of a 3′--5′ exonuclease activity in viral RNA polymerases and reverse transcriptases has been obtained from either biochemical or structural studies with viral enzymes ([@bib218]; [@bib78]). A possible exception was presented in an early report by ([@bib118]) showing that the influenza virus RNA polymerase was able to remove excess GMP residues added to a capped oligonucleotide primer. A 3′-end repair mechanism has been described in a satellite RNA of the plant virus turnip crinkle carmovirus, involving synthesis of short oligoribonucleotides by the viral replicase using the 3′-end of the viral genome as template, and, probably, template-independent priming at the 3′-end of the damaged RNA to generate wild-type, negative strand, satellite RNA ([@bib161]). Also, some coronaviruses encode a polymerase which includes a 3′--5' exonucleolytic activity (i.e. nsp14 of SARS) ([@bib155]). In the coronavirus murine hepatitis virus, mutations in the MSP14 exoribonuclease decreased replication fidelity ([@bib63a]).

Virus Entry into Error Catastrophe and its Application to Lethal Mutagenesis {#cesec3}
----------------------------------------------------------------------------

The limitations imposed on average mutation rates to maintain the genetic information transmitted by simple RNA replicons ([@bib220]; [@bib69]; [@bib173]) (Chapter 1) encouraged the first experiments to investigate whether chemical mutagenesis was detrimental to RNA virus replication. The first studies indicated that chemical mutagenesis could increase the mutation frequency by at most three-fold at defined genomic sites of poliovirus (PV) and vesicular stomatitis virus (VSV) ([@bib111]), and 13-fold in the case of a retroviral vector ([@bib179]). Also, increased mutagenesis had an adverse effect on fitness recovery of VSV clones ([@bib136]). These early results suggested that RNA viruses replicate near the error catastrophe threshold, with a copying fidelity that allows a generous production of error copies.

Additional studies in cell culture and *in vivo* have established that enhanced mutagenesis can result in virus extinction (reviewed in [@bib4]; [@bib47]). Loeb and colleagues coined the term "lethal mutagenesis" to refer to the loss of virus infectivity associated with the action of mutagenic agents ([@bib138]). Mutagenic nucleoside analogues, some used in antimicrobial and anticancer therapy, are currently actively studied as promoters of lethal mutagenesis of viruses, including an ongoing clinical trial with AIDS patients ([@bib106]).

Lethal mutagenesis is attracting increasing interest, and several theoretical models have addressed the mechanisms underlying lethal mutagenesis and the relationship between the observations on viral extinction and the original concept of error catastrophe (several models are reviewed in Chapter 1, and one model is described in Chapter 9). Key to the validation of these models as applied to RNA viruses is the experimental finding that a low viral load and low replicative fitness (relative replication capacity) favor extinction ([@bib215]; [@bib176]), and that a mutagenic activity (not merely an inhibitory activity) is necessary to achieve extinction ([@bib177]). This was shown by absence of extinction when the virus was subjected to equivalent inhibitory activities with cocktails of non-mutagenic inhibitors ([@bib177]). However, since low viral loads favor extinction, the inhibitory activity that is associated with the action of some mutagenic agents may contribute to lethal mutagenesis. In this respect, a combination of a mutagenic nucleoside analogue and the antiretroviral inhibitor AZT was required to extinguish high fitness HIV-1 during infections in cell culture ([@bib221]). Even strong reductions in population size of highly debilitated foot-and-mouth disease virus (FMDV) and lymphocytic choriomeningitis virus (LCMV) populations did not result in virus extinction unless a mutagenic activity intervened ([@bib215]; [@bib176]; [@bib177]). A second finding to be considered in the development of theoretical models is the negative interference exerted by mutants that either coinfect the cells along with standard virus, or are generated inside the cell by mutagenesis. The interfering activity of such "defector" genomes as contributing to viral extinction has been documented both experimentally with FMDV and LCMV, and by *in silico* simulations ([@bib95]; [@bib102]; [@bib183]). Production of a fraction of non-infectious hepatitis C virus (HCV) in infected patients as a result of ribavirin (1-β-D-ribofuranosyl-1,2,3-triazole-3-carboxamide) therapy is a key parameter in the models of HCV clearance following treatment with ribavirin and interferon alpha (IFN-α) ([@bib45]; [@bib40]) (see Chapter 15).

An argument that has been used to deny a connection between lethal mutagenesis and the transition into error catastrophe has been the absence of hypermutated molecules in mutagenized populations of RNA viruses. However, any hypermutated genome transiently generated during mutagenesis is unlikely to be replication-competent and to be included in any sampling of viral genomes. This has been recognized by us ([@bib101]) and others ([@bib184]). Despite this, a genome with a mutation frequency lying in the lower range of typically hypermutated genomes was identified in a population of 5-fluorouracil (5-FU)-treated LCMV ([@bib101]). The absence or very low frequency of hypermutated genomes in standard genome samplings of pre-extinction viral populations cannot constitute an argument against a mutagenesis-driven transition into error catastrophe.

Concerning the relationship between the concept of error catastrophe and extinction of viruses by lethal mutagenesis, M. Eigen pointed out the following: (i) dependence of copying fidelity on sequence context and the type of mutagen; (ii) fitness landscape of the quasispecies distribution, including the perturbing effects of specific types of mutants that may arise during mutagenesis (as discussed above); (iii) participation of multiple viral functions (not only RNA replication) in determining the replicative collapse of the system. As pointed out by Eigen, "Theory cannot remove complexity, but it shows what kind of 'regular' behavior can be expected and what experiments have to be done to get a grasp on the irregularities" ([@bib68]).

In line with the application of the error threshold relationship to real viruses ([@bib68]), it is obvious that virus extinction will not occur through "evaporation" into the entire sequence space theoretically available to a viral genome. This is physically impossible. As mutagenesis progresses during viral replication myriads of end-point genomes harboring lethal or highly deleterious mutations will impede further expansions into sequence space by such genomes. This is a consequence of the multiple viral functions (not only RNA replication) that affect replicative competence ([@bib68]). These differences between the mechanisms that mediate extinction of real viruses and the original concept of error catastrophe can be expressed by distinguishing "phenotypic" and "extinction" thresholds from an "error theshold," as has been done in some theoretical treatments (for example, [@bib116]; [@bib142]). Apart from these rather obvious adaptations of error catastrophe to a real biological system, the experimental studies carried out in the laboratory of one of us (E.D.) do not provide any basis to dissociate lethal mutagenesis from error catastrophe, as initially developed by Eigen, Schuster, and colleagues, and even less to consider that the approach to error catastrophe will impede viral extinction. In the section on "Intra-mutant spectrum suppression can contribute to lethal mutagenesis" in this chapter, we summarize our current view on the mechanisms that underlie virus extinction through lethal mutagenesis based on experimental results, and the main challenges facing, in our view, this new antiviral strategy.

INTRA-POPULATION COMPLEMENTATION AND INTERFERENCE IN VIRAL QUASISPECIES: MUTANT DISTRIBUTIONS AS THE UNITS OF SELECTION {#cesec4}
=======================================================================================================================

A viral quasispecies can have a biological behavior that is not predictable from the behavior of its components considered individually. Several observations with viruses as they replicate in cell culture or *in vivo* suggest that intra-population interactions can modulate the replicative capacity of the ensemble of mutants or of individual mutants introduced in a spectrum of mutants. Fitness of biological clones of bacteriophase Qβ ([@bib53]) and of VSV ([@bib61]) was lower than the fitness of the average populations from which the clones were derived. These quantifications of clonal fitness suggest that an ensemble of related mutants may collectively acquire a selective replicative advantage, perhaps because competent gene products may complement suboptimal or defective products expressed by subsets of components of the mutant spectrum. Specific mutants, including deleterious and lethal mutants, can be maintained in viral populations *in vivo*, and can be transmitted to susceptible hosts ([@bib157]; [@bib242]; [@bib1]; [@bib226]).

A seemingly opposite manifestation of the internal interactions within viral quasispecies is the suppression of the replication of specific mutants by the surrounding mutant spectrum. This possibility was suggested by theoretical models according to which a simple replicon of inferior fitness to another could nevertheless dominate the population by virtue of being surrounded by a more favorable mutant spectrum ([@bib220]) (reviewed in [@bib69]; [@bib171]) (Chapter 1). The first experimental documentation of this prediction with real viruses was by de la Torre and Holland who showed that a standard VSV population interfered with the replication of a VSV clone of superior fitness, unless the latter was present above a certain frequency in the population ([@bib43]). Suppressive effects of this type have been subsequently documented in several virus-host systems (reviewed in [@bib48]). Remarkable examples include suppression by attenuated PV of neuropathology in monkeys associated with virulent PV present in the vaccine preparation ([@bib39]), suppression of pathogenic LCMV by non-pathogenic variants ([@bib224]), the lowered replication rates of drug-resistant viruses ([@bib35]), and complementing-interfering effects of specific FMDV mutants ([@bib183]).

The Mutant Spectrum as a Determinant of Viral Pathogenesis. Picornaviral Polymerase Mutants {#cesec5}
-------------------------------------------------------------------------------------------

The complexity of the mutant spectrum of a virus (that is, the average number of mutations that distinguish the individual components of the mutant distribution) can affect the course of viral disease and the response to treatment. Most notably, prolonged persistence of HCV infection correlated with high mutant spectrum complexity ([@bib75]); other aspects of quasispecies behavior of HCV were reviewed in [@bib50]) (see also Chapter 15).

Studies with a PV mutant with an amino acid substitution in the viral polymerase which increases about five-fold its template-copying fidelity have been particularly revealing. The mutant PV produces a narrower mutant spectrum (with a lower average number of mutations per genome) than wild-type PV. In infections of susceptible mice (transgenic for the human PV receptor) the mutant replicated in the animals but failed to reach the brain and to produce the neuropathology that was associated with the infection with wild-type PV ([@bib188]; [@bib226]). Remarkably, restoration of the standard mutant spectrum complexity by subjecting the mutant PV to 5-FU-induced mutagenesis led to a neuropathogenic mutant spectrum ([@bib226]). Moreover, Sabin\'s attenuated PV vaccine shows relatively low mutant frequency compared with wild-type strains, and this observation could be due to differences in polymerase fidelity (Vignuzzi, personal communication; see also Chapter 6). These observations are highly relevant ([@bib15]). Foremost, the results show the biological relevance of high mutation rates, in that they may affect pathology by allowing the virus to reach specific target organs, thereby increasing viral loads and chances of transmission. The observed phenotypic transitions of PV demand consideration of the virus as a quasispecies, since PV behavior could not be explained by taking into account consensus genomic nucleotide sequences alone. We come to the conclusion that virus evolution can affect viral pathogenesis in at least two ways ([@bib49]): (i) The information for increased pathology or for adaptation to multiple environments can be contained in the genetic material of the virus (in most of its individual clones) irrespective of the mutant spectrum to which they belong ([@bib126]; [@bib103], among other examples). (ii) The information for increased pathology can be contained in a distribution of mutants as such, as documented above for HCV and PV. Again, these observations reinforce the biological advantage of high mutation rates for the long-term survival of RNA viruses, and the consideration of entire quasispecies as the units of selection (see also [@bib48], [@bib49], and other chapters of this volume).

The PV polymerase mutant displaying higher fidelity than the wild type was obtained by passaging the virus in the presence of increasing concentrations of the nucleoside analogue ribavirin ([@bib187]; [@bib226];. The amino acid replacement in the polymerase (G64S) is located away from the catalytic domain of the enzyme, and an action at a distance was invoked to explain the general effect of this substitution on the copying fidelity ([@bib9]) (see Chapter 6). A mutant of FMDV, selected also by passaging the virus in the presence of increasing concentrations of ribavirin, displayed higher fitness than the wild-type virus when virus replication took place in the presence of ribavirin but not in its absence ([@bib214]). This phenotypic change was mapped to amino acid substitution M296I in the viral polymerase, and the mutant enzyme displayed decreased capacity to use ribavirin triphosphate as substrate (instead of GTP or ATP), but did not show an apparent alteration of general template-copying fidelity ([@bib214]). Substitution M296I is located at a loop whose flexibility seems to be required to adapt its conformation and interactions to the size and shape of template residues and incoming nucleotide substrates. Ile at this position may restrict the loop flexibility and affect nucleotide recognition ([@bib79]). M296 is quite distant from the site (G62) where the equivalent, ribavirin-selected substitution in PV lays. These results suggest that in the picornaviral polymerase multiple sites (perhaps domains) might be involved either in specific interactions with nucleotide analogues or in recognition of nucleotide substrates.

Comparison of the structure of the FMDV polymerase complexed with RNA ([@bib77]), and with RNA and a number of nucleotides and nucleotide analogues ([@bib79]) has documented the involvement of multiple amino acids of the FMDV polymerase in the recognition of nucleotides. Several interactions are key to catalysis, as shown by modification of the polymerase activity of the corresponding mutants produced by site-directed mutagenesis. Interestingly, some interactions are common to standard nucleotides and nucleotide analogues, while other interactions are specific for a given nucleotide analogue ([@bib79]). These results suggest that multiple sites in the polymerase can modulate substrate recognition, thereby affecting the fidelity properties of picornaviral (and probably other) polymerases ([@bib9]; [@bib79]). These and other recent studies on the mechanism of substrate discrimination by viral RNA polymerases and reverse transcriptases are providing important information that may help in the design of drugs able to lower the copying fidelity of viral polymerases to facilitate lethal mutagenesis (see also Chapter 6).

Intra-Mutant Spectrum Suppression can Contribute to Lethal Mutagenesis {#cesec6}
----------------------------------------------------------------------

Populations of RNA viruses subjected to increased mutagenesis by nucleoside analogues display decreases in specific infectivity due to accumulation of viral genomes harboring deleterious or lethal mutations ([@bib34]; [@bib100], [@bib102]; [@bib2]; [@bib95], [@bib96]; [@bib7]). Mutagenized, pre-extinction FMDV RNA interfered with the replication of standard FMDV RNA, resulting in a delay and in a decrease in the production of progeny virus ([@bib95]). Since the interfering FMDV displayed at least a 0.1-fold fitness relative to the standard FMDV ([@bib96]), the suppression observed could not be due to mechanisms invoking competition between genomes of comparable replication capacity (such as positive clonal interference). It was suggested that the expression (normal or aberrant) of altered viral proteins could contribute to the suppression of replication of standard FMDV, and also to the extinction of FMDV RNA. To test this hypothesis, a number of capsid and polymerase mutants of FMDV were examined regarding their capacity to interfere with standard FMDV, in experiments involving coelectroporation of cells with the relevant RNAs ([@bib183]). The results showed that an excess of several replication-competent mutants caused a strong and specific interference on FMDV replication. Furthermore, mixtures of some capsid and polymerase mutants evoked a very strong, synergistic interference ([@bib183]). Notably, some of the mutants tested had been isolated from mutagenized FMDV populations in their way towards extinction. These results with FMDV are in agreement with observations on enhanced mutagenesis of LCMV which resulted in populations in which the loss of infectious progeny production preceded the loss of replicating viral RNA ([@bib102]). A deleterious effect on infectivity exerted by defective LCMV genomes was also supported by numerical simulations using realistic parameters of LCMV replication ([@bib102]).

The picture emerging from the studies with FMDV and LCMV is that the transition towards viral extinction associated with lethal mutagenesis can have at least two phases: an initial one, with a limited input of mutations in the viral genomes, in which a subset of defective genomes that have been termed "defectors" interfere with replication of standard genomes, and can contribute to viral extinction. This is termed the "lethal defection model" of virus extinction, proposed on the basis of experiments with LCMV ([@bib102]), and supported by the strong interference on FMDV replication exerted by combinations of specific capsid and polymerase mutants of FMDV ([@bib183]). In a second phase, as the number of mutations per genome increases due to continuing mutagenesis, the proportion of lethal mutations increases, resulting in further decreases in specific infectivity ([@bib96]; [@bib102]). In Chapter 6, Cameron and colleagues describe elegant experiments that show that low-fidelity mutants of poliovirus manifest an acceleration of the onset of lethal mutagenesis. Genomes with either deleterious or lethal mutations have been isolated from mutagenized FMDV and LCMV populations on their way towards extinction ([@bib215]; [@bib176]; [@bib7]). Some detrimental mutations may be maintained in the viral populations by complementation and whenever the genomes harboring them increase in frequency they may exert an interfering activity provided that the type of genetic lesion belongs to the interfering class ([@bib183]). Interestingly, some genomes harboring multiple mutations (for example a triple mutant in the polymerase of FMDV) that render the genome replication-incompetent may differ in a single nucleotide position from a replication-competent, strongly interfering mutant ([@bib7]; [@bib183]). Viral genomes with interfering or lethal mutations may occupy proximal or distant positions in sequence space, relative to the standard, non-mutated genome. Thus, there might be a gradual but overlapping transition between a phase of dominance of interfering mutants and a phase of increasing presence of lethal mutants, until a replicative collapse and virus extinction occur, in agreement with the theory of error catastrophe (see Chapter 1 for a discussion of the contribution of lethal mutants to error catastrophe). Recent biochemical data have documented that viral proteins are frequently multifunctional and that they often form oligomeric complexes. Thus, mutated forms of a given protein may affect multiple viral functions and result in inactive protein complexes (several examples can be found in [@bib153]; [@bib217]). Abnormal behavior of altered viral proteins may be one of the molecular mechanisms underlying virus transition into error catastrophe, very much in line with the cascade of events initially proposed as a model for aging ([@bib175]).

The transition of FMDV and LCMV towards extinction by lethal mutagenesis occurred with a 10^2^- to 10^3^-fold decrease in specific infectivity (PFU/total viral RNA), and without a modification of the consensus sequence of the population ([@bib95]; [@bib101]) in agreement with results with poliovirus ([@bib34]). Loss of infectivity was very sharp, and extinction occurred generally after 1--20 passages, depending on viral fitness and the mutagen-inhibitor combination treatment (compare the extinction kinetics in [@bib215]; [@bib176], [@bib177]; [@bib101]). Extinction can be preceded by minimal increase in the average mutation frequency of the mutant spectra ([@bib34]; [@bib102]; [@bib221]). These experiments have not provided evidence that as the mutational load in the viral genome increases, the virus acquires resistance to extinction. It remains to be seen whether the presence of M296I in the FMDV RdRp, which was selected by ribavirin, confers any significant resistance to lethal mutagenesis. The vulnerability of FMDV to extinction by lethal mutagenesis offers a significant contrast with the resistance of FMDV to extinction despite accumulation of mutations as a result of plaque-to-plaque transfers ([@bib73], [@bib74a]; [@bib134]). The key difference between the two scenarios is that resistance to extinction (despite accumulation of mutations accompanying serial bottleneck events) results from the selection for a next transfer of a virus able to replicate thanks to the presence of compensatory mutations. This is in contrast to mutagenesis of a complex population whose suppressive effects do not allow the rescuing of replication-competent individuals ([@bib142]).

The course of events preceding viral extinction that we have outlined here has a number of experimentally testable predictions, currently under study. Clarification of the mechanisms underlying virus extinction may help in the design of improved protocols of administration of mutagenic agents and antiviral inhibitors for lethal mutagenesis. In our view, the main challenges facing progress in lethal mutagenesis are: (i) finding and design of new mutagenic base or nucleoside analogues that target viral (but not cellular) polymerases, that can be used in combination with antiviral inhibitors; (ii) evaluation of how widespread is the occurrence of mutagen-resistant virus mutants, and whether lethal mutagenesis may fail either because of the presence of mutagen-resistant mutations ([@bib187]) [@bib214]) or other mechanisms ([@bib205]); (iii) understanding of the molecular basis of template-copying fidelity of nucleic acid polymerases, and the design of drugs that can lower specifically the copying fidelity of viral polymerases; (iv) the application of lethal mutagenesis to model systems *in vivo* ([@bib202]; [@bib106]). Concerning possible applications of lethal mutagenesis *in vivo*, measurements of the "critical drug efficacy"---as developed for treatments of infections by HIV-1 and HCV ([@bib22]; [@bib115]; [@bib40])---for mutagen-inhibitor combinations, should guide in establishing protocols adequate for viral clearance, to avoid stabilization of viral levels at a therapy-induced set point.

FITNESS AND ITS MODULATION BY VIRAL POPULATION SIZE {#cesec7}
===================================================

One of the consequences of the quasispecies dynamics of RNA viruses is fitness variations in a constant environment triggered by changes in viral population size. Fitness is a complex parameter that measures the degree of adaptation of a living organism or simple replicons to a specific environment (as general reviews see [@bib238]) and [@bib196]). For viruses, fitness values have been measured as the relative ability of two competing viruses to produce infectious progeny ([@bib112]; reviewed in [@bib51]; [@bib193]). In the standard protocol, competitions are started by infecting cells or organisms with a mixture of a reference wild-type virus (given arbitrarily a fitness value of 1) and the virus to be tested, in known proportions. The progeny viruses are used to initiate a second round of infection, and the process is repeated a number of times (serial infections). Then, the logarithm of the proportion of the two competing viruses at each passage defines a fitness vector, the slope of which is the logarithm of the fitness of the test virus relative to the reference virus ([Figure 4.1](#f1){ref-type="fig"} ). The two competing viruses must be distinguishable by some phenotypic trait (e.g. a clear difference in the ability to replicate in the presence of an antibody or a drug) or by some genetic change, such as nucleotide substitutions that allow the proportion of the two viruses to be determined by densitometry of a sequencing gel or by their specific amplification by real time reverse transcription-polymerase chain reaction (RT-PCR) using discriminatory oligonucleotide primers.FIGURE 4.1Schematic representation of fitness vectors and some patterns of fitness variation. (A) Plot of the proportion of the test virus and the reference virus, relative to the initial mixture, as a function of passage number. The plot gives a fitness vector. The test virus can show higher relative fitness than the reference virus (line 1), equal fitness (neutrality, line 2), or lower fitness than the reference virus (line 3). See text for comments and literature references. (B) Possible outcomes of a competition between two neutral variants. The two variants may co-exist for many generations (line 1). Occasionally one variant may displace the other in a rather unpredictable manner (lines 2 and 3), in agreement with the competitive exclusion principle of population genetics. Further information and references are given in the text.

Fitness determinations of viruses subjected to different passage regimes have established an important effect of population size of the virus involved in the infections, on fitness evolution.

Fitness Decrease Upon Bottleneck Passages. Viral Virulence May Not Correlate with Fitness {#cesec8}
-----------------------------------------------------------------------------------------

Animal viruses are likely to undergo genetic bottlenecks during transmission; most of the evidence suggesting bottleneck effects comes from sequence analysis of infected hosts (for instance, [@bib83]), but Pfeiffer and Kirkegaard demonstrated bottlenecks during PV transmission from inoculated sites to the brain in transgenic mice expressing the human PV receptor ([@bib189]). In addition, there is direct evidence demonstrating that plant viruses experience significant bottlenecks during movement from the site of infection ([@bib3]; [@bib122]) (see Chapter 12).

RNA virus populations subjected to severe serial bottleneck events in cell culture---such as those occurring upon serial plaque-to-plaque transfers---undergo, on average, a decrease in fitness ([@bib36]; [@bib60]; [@bib71]; [@bib246]; [@bib42]). This is due to the stochastic accumulation of deleterious mutations ([Figure 4.2](#f2){ref-type="fig"} ), predicted by [@bib158a] to occur for small populations of asexual organisms lacking in mechanisms, such as sex or recombination, that could eliminate or compensate for such debilitating mutations ([@bib149]). Subjecting RNA viruses to repeated plaque-to-plaque transfers has all the ingredients to accentuate the effects of Müller\'s ratchet: a viral population reduced to a single genome at the onset of plaque formation (extreme genetic drift), and high mutation rates.FIGURE 4.2Schematic representation of viral quasispecies and the effect of viral population size on replicative fitness. Horizontal lines represent genomes and symbols on the lines represent mutations. Random sampling of genomes (bottleneck events, small arrows) lead to accumulation of mutations and fitness decrease. Large population passages (large arrows) lead to increases in replicative fitness. Fitness losses or gains depend on the initial fitness of the viral population and the size of the bottleneck. See text for details and references.

A study by [@bib166] using VSV established that the extent of fitness loss for any given bottleneck size depends on the initial fitness of the viral clone under study. The higher the initial fitness, the less severe must the bottleneck be to avoid fitness losses. Debilitated viral clones often gain fitness even when subjected to considerable bottlenecking ([@bib164], [@bib166]). Rather constant, stable fitness values could be attained by choosing the appropriate bottleneck size, although occasional fitness jumps were observed ([@bib167]).

[@bib71], [@bib74a] examined the genetic lesions associated with Müller\'s ratchet by determining genomic nucleotide sequences of FMDV clones prior to and after undergoing repeated (up to 409) plaque-to-plaque transfers. The result was that fitness loss was associated with unusual mutations that had never been seen in natural FMDV isolates or laboratory populations subjected to passages involving large viral populations. Particularly striking were an internal polyadenylate extension preceding the second functional AUG initiation codon of the FMDV genome, and amino acid substitutions at internal capsid residues. Additions or deletions of nucleotides have been frequently observed at homopolymeric tracts, particularly on pyrimidine runs in templates copied by proofreading-repair-deficient polymerases ([@bib131]; [@bib14]). The experimental results suggest that only when the repeated bottlenecks limit the action of negative selection (elimination or decrease in proportion of low fitness genomes) can such internal polyadenylate extensions (and other deleterious mutations) be maintained in the FMDV genome ([@bib71], [@bib74]). In contrast, sequence analysis of VSV genomes subjected to plaque-to-plaque passages did not show unusual mutations, with the possible exception of mutations in the RNA termini, which are uncommon in viruses evolving in regimes of acute replication ([@bib163]).

Fitness decrease upon subjecting FMDV to plaque-to-plaque transfers was biphasic: an initial decrease was followed by a highly fluctuating pattern with a constant average fitness value. The fluctuating pattern followed a Weibull statistical distribution ([@bib230]; [@bib134]). A Weibull distribution describes disparate physical and biological processes. In the case of plaque-to-plaque transfers of a virus this type of distribution probably results from the multiple host--virus interactions that occur as the virus life cycle is completed, and alterations of such interactions as mutations accumulate in multifunctional viral proteins ([@bib134]). The studies of evolution of FMDV when subjected to many repeated serial bottleneck transfers revealed a remarkable resistance of the virus to extinction despite a linear accumulation of mutations in its genome ([@bib73]), as well as the existence of multiple evolutionary pathways for fitness recovery ([@bib72]) (see also "Intra-mutant spectrum suppression can contribute to lethal mutagenesis," above).

Fitness has often been considered a component of parasite virulence, defined as the capacity of parasites to inflict damage upon their hosts. Indeed, very frequently an increase in viral fitness parallels an increase of virulence. However, a comparative quantitative analysis of fitness and virulence (cell-killing capacity) of an FMDV clone subjected to plaque-to-plaque transfers, and of its parental clone, revealed that fitness and virulence can be two unrelated traits ([@bib107]). The molecular basis for the different trajectories followed by fitness and virulence resided in the fact that fitness was affected by mutations anywhere in the viral genome while determinants of cell-killing capacity were multigenic but restricted to some specific genomic regions of the viral genome. As a consequence, the random accumulation of mutations associated with bottleneck transfers had a more negative impact on fitness than on virulence of this FMDV clone ([@bib107]). That viral fitness and virulence can follow different trajectories is supported by several observations with animal and plant viruses. VSV populations that were subjected to a regime of persistent infection in sandfly cells showed overall decrease in both fitness and virulence in mammalian cells, but the decrease in virulence continued throughout the experiment, while the decrease in fitness peaked at intermediate passages and was followed by some degree of recovery ([@bib247]). Simian immunodeficiency virus SIVmac239 attains similar high viral loads in the sooty mangabey and the rhesus macaque, yet it is only virulent for the rhesus macaque ([@bib124]). At an epidemiological level, greater fitness of historical versus current HIV-1 isolates was taken as evidence of HIV-1 attenuation over time, assuming a direct correlation between fitness and virulence ([@bib8]). However, no trend towards HIV-1 attenuation since the time of introduction of the virus into Switzerland was observed ([@bib159]). These and other studies with viral and non-viral parasites (reviewed in [@bib107]) suggest that evolution in nature can drive parasites to attain virulence levels that are not necessarily coupled to fitness. This distinction between fitness and virulence should be taken into consideration in the formulation of models for parasite virulence.

Fitness Gain Upon Large Population Passages: Limitations, Exclusions, Memory and Molecular Transitions {#cesec9}
------------------------------------------------------------------------------------------------------

In contrast to bottleneck passages, large population infections generally result in fitness gains of RNA viruses ([@bib146]; [@bib27]; [@bib165]; [@bib72]). Fitness increase in this case is expected from a gradual optimization of mutant spectra when their different components, arising by mutation and in some cases also by recombination, are allowed unrestricted competition in a constant environment ([Figure 4.2](#f2){ref-type="fig"}). High replicative fitness may help a virus to overcome selective constraints---including antiviral agents or immune responses ([@bib193]; [@bib104])---and to delay extinction by lethal mutagenesis ([@bib215]; [@bib176]).

When the relative fitness of the evolving quasispecies reaches a high value, even quite large population sizes can constitute an effective bottleneck and prevent continuing fitness increase ([@bib168], [@bib169]). This limiting high fitness level was manifested by stochastic fluctuations in fitness values expected from random generation of mutations in a continuously evolving mutant swarm. These perturbations illustrate how difficult it is to attain a true population equilibrium even when viruses replicate in a constant environment. A rare combination of mutations---one that may occur only once over many rounds of viral replication---may transfer one genome and its descendants to a distant region of sequence space, and trigger the dominance of one viral subpopulation over another, thereby disrupting a period of population equilibrium. In competitions between two VSV clones of similar fitness coexisting at or near equilibrium, a rapid and unpredictable displacement of one VSV population by the other ([@bib28]) provided support for a classical concept of population biology: the competitive exclusion principle ([@bib92]). Furthermore, in the competition passages preceding mutual exclusion, both the winners and the losers gained fitness at comparable rates, in support of yet another concept of population genetics: the Red Queen hypothesis ([@bib225]; [@bib28]; reviewed in [@bib48]) (see [Figure 4.1](#f1){ref-type="fig"}).

Parallel fitness gains were also observed for minority memory genomes and their majority counterparts in evolving FMDV quasispecies ([@bib6]). Memory genomes are subpopulations of genomes that remain in a replicating viral quasispecies at a frequency about 10^2^- to 10^3^-fold higher than the frequency that can be attributed to mutational pressure alone, and reflect those genomes that were dominant at a previous stage of the evolution of the same viral lineage ([@bib200]; review in [@bib46]). Memory has been documented with a number of genetic markers of FMDV ([@bib200], [@bib201], [@bib203]) and HIV-1 ([@bib19], [@bib20]), and similar results have been described for VSV ([@bib170]). Memory is a consequence of fitness variations inherent to quasispecies dynamics, likely to exert its main influence on the composition of mutant spectra that have been subjected to various alternating selective pressures ([@bib46]).

Relative viral fitness may depend on the multiplicity of infection (m.o.i.) used during selection or competition. High m.o.i. promotes coinfection, and the higher the level of coinfection the more likely that complementation will take place. Complementation effectively hides beneficial (and deleterious) variation from the effects of selection ([@bib209]; [@bib233]; [@bib236]). In addition, high m.o.i. effects may relate to the use of alternative receptors or to interfering interactions occurring within the mutant spectra of viral quasispecies ([@bib209]; [@bib183]) (see section on "Intra-population complementation and interference in viral quasispecies: mutant distributions as the units of selection").

Defective viruses can be maintained in the course of high m.o.i. passages by complementation. An extensively documented case is the generation and maintenance of helper-dependent defective-interfering (DI) RNA and particles, which follow the process of mutation, competition and selection typical of quasispecies dynamics ([@bib110]; [@bib199]). Other types of defective genomes can also be maintained in viral populations by complementation ([@bib37]; [@bib157]; [@bib242]). Some defective genomes can be transmitted from infected into susceptible hosts, rendering the maintenance of defective genomes by complementation an event of potential epidemiological significance ([@bib1]).

A striking, extreme case of complementation between defective genomes was provided by evolution of standard FMDV towards two defective forms that were infectious and killed cells by complementation in the absence of standard FMDV [@bib86], [@bib87], [@bib88]. These studies have provided evidence of a continuous dynamics of generation of defective FMDV genomes harboring in-frame internal deletions within genomic regions encoding *trans*-acting proteins, giving rise to swarms of genomes with non-identical, related deletions ([@bib88]). Each virion encapsidates only one type of defective genome and, therefore, the same cell must be infected by at least two different particles to permit complementation and formation of progeny defective genomes ([@bib143];. The high m.o.i.-dependent evolution of FMDV towards two defective forms that can complement each other has been regarded as experimental support of a first step in a process towards viral genome segmentation. Interestingly, multipartite segmented genomes are rare among the animal and bacterial viruses but are frequent among plant viruses, and the latter are characterized by high m.o.i. as they spread in their host plants ([@bib135]).

The main conclusion we derive from the results summarized in the preceding paragraphs is that even in a relatively constant biological and physical environment, as is usually provided by *in vitro* cell culture systems, the degree of adaptation of viral quasispecies may undergo remarkable quantitative variations, prompted by the stochastic generation of mutant genomes, and different opportunities for competitive optimization of mutant spectra.

FITNESS VARIATIONS IN CHANGING ENVIRONMENTS {#cesec10}
===========================================

The experiments of fitness variation of viruses in cell culture summarized in the previous section have been instrumental in defining some basic influences that guide fitness evolution of viral quasispecies. However, in their replication in a natural setting, viruses encounter multiple and changing environments, and they often have to cope with conflicting selective constraints. Because of polymorphisms in key host proteins involved in cellular and humoral immune responses, and in many other cell surface antigens, viruses do not face the same selective constraints in different individuals of the same host species. Biological environments are heterogeneous and vary with time within each infected individual. Furthermore, a considerable number of viruses are capable of infecting different host species, extending even further the range of environments they face.

Arboviruses that replicate in mammalian and insect hosts constitute a classical example of obligate environmental alternacy *in vivo* ([@bib206]; [@bib229]) (Chapter 16). Early work documented that extensive replication of viruses in insect cells led to attenuation of infectivity for mammalian cells ([@bib181]; [@bib158]). Prolonged persistence of VSV in sandfly cells cultured at low temperatures resulted in several orders of magnitude greater fitness in insect cells than in mammalian cells ([@bib164]; [@bib247]). In contrast, acute VSV replication in sandfly cells led to fitness increase in mammalian cells ([@bib168]), and replication of West Nile virus in mosquito cells resulted in populations that, while not improved, showed no fitness losses in vertebrate cells ([@bib25]). Thus, we cannot assume selective differences between insect and mammalian cells types, and when we observe tradeoffs, these may be due to different strategies of replication (persistent versus acute), not to difference in cell type *per se.*

A single passage of sandfly cell-adapted VSV in mammalian cells led to an increase in fitness in mammalian cells to near original values. It would be interesting to test whether this capacity for fitness shift would be similar for non-arboviral RNA viruses able to grow in insect cells in culture. VSV adapted to sandfly cells was highly attenuated for mice. Again, a single passage in mammalian cells restored the virulence phenotype *in vivo* ([@bib164]).

Several groups have studied the evolutionary consequences of alternating environments during arbovirus replication (reviewed in [@bib237]; [@bib25]). The overall results showed that extensive alternating replication between mammalian and insect cells led to fitness improvement in both environments; the only exception was VSV adapted to alternation between persistent insect replication and acute mammalian replication: adaptation during alternation is dominated by the persistent environment and there is fitness loss in the mammalian environment ([@bib247]) (for details, see Chapter 16).

Studies of fitness variations *in vivo* have been approached in at least three ways. Some studies have involved growth-competition experiments between two viruses replicating in host organisms. In other studies, the outcome of competitions between viruses that were iso-lated in *vivo* has been analyzed in primary or established cell cultures. In yet another line of research, the effect of fitness variations in cell culture on the replicative potential of viruses *in vivo* has been examined.

[@bib23] isolated two variant FMDVs present at low frequency in the course of replication of a clonal virus preparation in swine. One of the variants was a MAb-resistant mutant (MARM), while the other was isolated from blood during the early viremic phase of the acute infection. The ability of the two variants to compete *in vivo* with the parental clonal population was examined by coinfection of swine with mixtures of the parental clone and each of the two variants individually. None of the two variants became completely dominant in a single coinfection *in vivo*, but fitness differences were clearly documented. The parental FMDV clone manifested a selective advantage over the MARM in that the parental clone was dominant in most lesions (vesicles) in the diseased swine. In contrast, the parental clone and the variant from the early viremic phase were about equally represented in the lesions of the animals infected with equal amounts of the two viruses ([@bib23]).

The lentivirus equine infectious anemia virus (EIAV) experiences continuous quasispecies fluctuations during persistent infections in horses ([@bib29]). EIAV quasispecies were characterized in a pony experimentally infected with a biological clone of the virus. New quasispecies were associated with recurrent episodes of disease. A large deletion in the principal neutralizing domain of the virus was identified during the third febrile episode and became dominant during the fourth febrile episode. This drastic genetic change did not appear to diminish significantly the fitness of EIAV *in vivo* and in cell culture ([@bib137]). The complexity of sequential EIAV populations *in vivo*, was characterized with a non-hierarchical clustering method to analyze quasispecies, termed PAQ (partition analysis of quasispecies) ([@bib11]). This procedure to dissect the composition of mutant spectra should allow the recognition of subpopulations within viral quasispecies as they evolve towards fitness gain or loss.

Fitness Variations in Viral Disease Emergence and Reemergence. The Case of Human Influenza Virus {#cesec11}
------------------------------------------------------------------------------------------------

The multiple environments in which viruses have to replicate *in vivo* may promote the selective expansion of subpopulations from viral quasispecies thereby leading to variant viruses that display altered relative fitness in different host organs, as compared with their parental populations. Such variations in the potential replicative capacity constitute one of the ingredients that may affect the emergence and reemergence of viral disease (reviews in [@bib216]; [@bib185]). The genetic lottery of blind variation through mutation, recombination, and genome segment reassortment is played in the face of a background of multiple ecological, sociological, and demographic factors. In recent decades viral disease emergences that have affected humans have occurred at a rate of about one per year. Salient examples are acquired immune deficiency syndrome (AIDS), severe acute respiratory syndrome (SARS), encephalitis associated with West Nile virus, the expansion of dengue fever, or periodic influenza pandemics ([@bib216]; [@bib185]).

Multiple genetic changes may favor the adaptation of a virus to a new host. Once adaptation has taken place, the adapted virus may lose or maintain the pathogenic potential for the former (donor) host (as an example of maintenance of virulence for a donor and recipient host in FMDV see [@bib174]). A core (or basal) genetic composition of a viral pathogen may be in itself a predictor of pathogenic potential, as profusely documented with natural or laboratory-generated, attenuated variants of many viral pathogens. To take influenza A virus and the threat of a human influenza pandemics as examples, out of the 16 hemagglutinin (H) and 9 neuraminidase (N) subtypes circulating among animal reservoirs, some potentially threatening forms being more carefully kept under surveillance include H~5~ N~1~, H~7~N~7~, H~9~N~2~, and H~2~N~2~ viruses. The expansion of the H~5~N~1~ subtype among wild and domestic avian species and human contacts since 2005 has resulted in over 300 human cases in nearly 50 countries, with more than 50% deaths, as well as the killing of millions of poultry ([@bib240]). Key parameters for an avian influenza virus to give rise to a human influenza pandemic include acquisition of receptor-recognition specificity for human cells, and the capacity for efficient human-to-human transmission ([@bib178]; [@bib219]). This capacity can be expressed as the basic reproductive ratio (Ro) which is the average number of infected contacts from each infected host (review in [@bib172]). "Epidemiologic fitness" has been used to describe (through samplings of definitory genomic sequences, diagnostic surveys, etc.) the capacity of a virus to become dominant (relative to related viruses or variants) during epidemic outbreaks ([@bib49]). In the case of human influenza virus, the acquisition of high epidemiological fitness depends on multiple gene products. Critical substitutions in H may modify the receptor-binding specificity of influenza viruses, and such substitutions have been found in minority subpopulations of influenza virus in several surveys. In one study, two substitutions in H identified in a human influenza virus from a fatal human case, were shown to modify the receptor-binding preference of H of a H~5~N~1~ virus from sialic acid-α2,3 galactose (associated with replication in avian hosts) to both sialic acid-α2,3 galactose and sialic acid-α2,6 galactose, both associated with binding to human-type receptors, each expressed preferentially in different sites of the human respiratory tract ([@bib10]). Thus, in influenza virus, and probably many other pathogenic viruses, both epidemiologic fitness and replicative fitness are multigenic traits ([@bib104]).

Several studies have compared the amino acid sequence of multiple influenza virus proteins to search for markers (amino acid substitutions) of human isolates and human pandemic strains (from 1918, 1957, 1968 and recent human H~5~N~1~ isolates). In one such proteomics survey, several amino acid changes located in PB2, PA, NP, M1, and NS1 distinguished avian influenza viruses from their human counterparts ([@bib80]). Some markers were conserved in the influenza viruses that caused the 1918, 1957, and 1968 pandemics. Other studies have identified HA and PB2 as critical for adaptation of avian virus to humans, that may occur by a step-wise process reflected in acquisition of diagnostic amino acid markers. Evidence of human-to-human transmission of avian influenza virus H~5~N~1~ has been obtained in some family case clusters but not in others ([@bib243]). Influenza constitutes the paradigm of a viral disease which, favored by a continuum of genetic variation, reemerges periodically to cause pandemics, and for which extensive epidemiological surveillance is currently in operation.

Fitness and Drug Resistance in HIV-1 {#cesec12}
------------------------------------

An increasing number of measurements of viral fitness involve human immunodeficiency virus 1 (HIV-1) variants isolated from quasispecies replicating *in vivo.* Particularly relevant are fitness comparisons among multiple mutants harboring amino acid substitutions related to resistance to reverse transcriptase and protease inhibitors (see also Chapter 14).

### HIV-1 Reverse Transcriptase (RT) Inhibitors {#cesec13}

Since the discovery of AZT (3′-azido-3′-deoxythymidine, zidovudine) as an effective inhibitor of HIV replication ([@bib156]), drug therapy has been widely used in the treatment of AIDS. The loss of therapeutic effect due to the acquisition of resistance was recognized for AZT in 1989, when Larder and colleagues showed that HIV isolates from patients with advanced HIV disease became less sensitive to the drug during the course of treatment ([@bib133]). High-level resistance to AZT is achieved through the accumulation of several mutations including M41L, D67N, K70R, L210W, T215Y/F, and K219Q/E (for a review, see [@bib132]). The first substitution arising during AZT treatment is usually K70R, followed by T215Y. The K70R mutation appears frequently, since it requires only one nucleotide change, and does not have a major impact on viral fitness ([@bib105]). The simultaneous presence of Leu41 and Tyr215 in the viral RT-coding region confers high-level resistance to AZT, without having a major effect on viral fitness. In contrast, other combinations of AZT resistance mutations (e.g. M41L/K70R) confer reduced replication capacity ([@bib120]). Interestingly, transmitted HIV-1 carrying D67N or K219Q evolve rapidly to AZT resistance *in vitro* (selecting for K70R) and show a high replicative fitness in the presence of zidovudine ([@bib86]). On the other hand, L210W improved infectivity and relative fitness of an M41L/T215Y mutant in the presence of AZT, but decreased infectivity and relative fitness when introduced into a D67N/K70R/K219Q background ([@bib113]).

Drug-resistant mutations occur in the mutant spectra of HIV-1 quasispecies from untreated patients ([@bib162]). The replacement of Tyr215 by Cys, Asp, or Ser has been observed *in vivo* in the absence of zidovudine treatment ([@bib99]; [@bib244]). In the absence of inhibitor, T215S and T215D confer a small but significant advantage over the wild-type virus, as determined *in vitro* in growth competition experiments. However, the replicative advantage conferred by T215S was lost in the presence of zidovudine-resistance mutations such as M41L and L210W ([@bib85]).

Other nucleoside inhibitors of HIV-1 RT are listed in [Table 4.1](#cetable1){ref-type="table"} . High-level resistance to the nucleoside analogue 3TC (2′,3′-dideoxy-3′-thiacytidine, lamivudine) is rapidly achieved by the substitution M184 V, located at the YMDD motif, which is part of the catalytic core of the enzyme. During 3TC treatment, the substitution M184I appears first, but then it is lost due to the outgrowth of the M184V-containing viruses ([@bib125]). Growth competition experiments showed a selective advantage of viruses with Val184 over those with Ile184. The low efficiency of 3TC-resistant HIV-1, carrying RT mutations M184V or M184I, has been attributed to the low processivity of the mutant RT ([@bib12]), which was accentuated in peripheral blood mononuclear cells (PBMCs) ([@bib125]).TABLE 4.1Amino Acid Substitutions Associated with HIV-1 Resistance to Antiretroviral DrugsInhibitorsAmino acid substitutions associated with drug resistance[a](#cetablefn1){ref-type="table-fn"}*Nucleoside analogue RT inhibitors*Zidovudine (AZT)M41L, D67N, K70R, L210W, T215Y/F, K219Q/EDidanosine (ddI)K65R, L74VLamivudine (3TC)(E44D/V118I), K65R, M184V/IStavudine (d4T)M41L, D67N, K70R, V75T, V118I, L210W, T215Y/F, K219Q/EZalcitabine (ddC)K65R, T69D, L74V, M184VAbacavirK65R, L74V, Y115F, M184VEmtricitabine(K65R/Q151 M), M184V/ITenofovirK65R, K70EMultiple nucleoside analogues(i) M41L, D67N, K70R, L210W, T215F/Y, K219Q/E; (ii) A62V, V75I, F77L, F116Y, Q151M; (iii) Insertions between codons 69--70 (e.g. T69SSS, T69SSG, T69SSA, etc.), M41L, A62V, K70R, L210W, T215Y/F*Non-nucleoside analogue RT inhibitors*NevirapineL100I, K101P, K103N/S, V106A/M, V108I, Y181C/I, Y188C/L/H, G190A/C/E/Q/S/TDelavirdineK103H/N/T, V106M, Y181C, Y188L, G190E, P236LEfavirenzL100I, K103H/N, V106M, V108I, Y188L, G190A/S/T, P225H*PR inhibitors*[b](#cetablefn2){ref-type="table-fn"}L10I/R/V, **G48V,** I54L/V, A71T/V, G73S, V77I, V82A, I84V, **L90M**SaquinavirRitonavirL10I/R/V, K20M/R, V32I, L33F, M36I, M46I/L, I54V/L, A71V/T, V77I, **V82A/F/S/T, I84V,** L90MIndinavirL10I/R/V, K20M/R, L24I, V32I, M36I, **M46I/L,** I54V, A71T/V, G73A/S, V77I, **V82A/F/S/T, I84V,** L90MNelfinavirL10F/I, **D30N,** M36I, M46I/L, A71T/V, V77I, V82A/F/S/T, I84V, N88D/S, **L90M**AmprenavirL10F/I/R/V, V32I, M46I/L, I47V, **I50V,** I54M/V, **I84V,** L90MLopinavirL10F/I/R/V, G16E, K20I/M/R, L24I, V32I, L33F, E34Q, M36I/L, K43T, **M46I/L, I47A/V,** G48M/V, I50V, **I54L/V**/A/M/S/T, Q58E, L63T, A71T, G73T, T74S, **V82A**/F/S/T, I84V, L89I/MAtazanavirL10F/I/V, K20I/M/R, L24I, L33F/I/V, M36I/L/V, M46I/L, G48V, **I50L,** I54L/V, L63P, A71I/T/V, G73A/C/S/T, V82A/F/S/T, **I84V, N88S,** L90MTipranavirL10I/S/V, I13V, K20M/R, **L33F/I/V,** E35G, M36I/L/V, K43T, M46L, I47V, I54A/M/V, Q58E, H69 K, T74P, **V82L/T,** N83D, **I84V,** L90MDarunavirV11I, V32I, L33F, I47V, **I50V,** I54L/M, G73S, L76V, I84V, L89V*Fusion inhibitors*G36D/E/S, I37T/V, V38A/M/E, Q40H, N42T, N43D/K/SEnfuvirtide[^1][^2]

Other nucleoside analogue resistance mutations (e.g. K65R, K70E, or L74V) also have a significant impact on viral fitness, which correlates with a defect in RT processivity ([@bib211]; [@bib154]; [@bib212]; [@bib232]). The presence of K65R together with L74V or M184V has a strong deleterious effect on viral replication, due to the poor ability of K65R/L74V to use natural nucleotides relative to the wild type ([@bib44]), or to the negative impact of the simultaneous presence of K65R and M184V on the RT\'s processivity, as well as in the initiation of reverse transcription ([@bib232]; [@bib81]). These observations are consistent with the low prevalence of the K65R mutation among isolates from antiretroviral-drug experienced patients, and give rational support to the benefit in combining mutations that impair virus replication.

Drug combinations are very effective in blocking HIV replication, leading to a more than 10000-fold reduction of viral load. Early studies showed that multiple drug resistance to AZT and other inhibitors can be achieved through the accumulation of mutations appearing in monotherapy ([@bib207]; [@bib210]). However, the response of a viral quasispecies to multiple constraints (e.g. different antiviral drugs) is often difficult to predict. Simultaneous treatment with AZT and ddI led to viruses with reduced sensitivity to AZT, ddC, ddI, ddG, and d4T ([@bib213]; [@bib119]). The resistant viruses contained substitutions A62V, V75I, F77L, F116Y, and Q151 M. Substitution Q151 M, which results from two nucleotide changes, is the first to appear and confers partial resistance to AZT, ddI, ddC, and d4T. Fitness assays involving the determination of replication kinetics or growth competition experiments showed that mutations at codons 62, 75, 77, and 116 improved the replication capacity of the resistant virus ([@bib141]; [@bib130]).

With the increasing complexity of the antiretroviral regimens, novel mutational patterns conferring resistance to multiple antiretroviral drugs have been identified. Thus, HIV-1 variants with insertions or deletions in the "fingers" subdomain of the RT have been found in patients failing therapy with multiple RT inhibitors ([@bib147]; for a recent review, see [@bib152]). The presence of the amino acid changes T69S and T215Y in the RT, together with a dipeptide insertion between positions 69 and 70 (usually Ser-Ser), and the subsequent accumulation of additional mutations (e.g. M41L, A62V, T69S, and K70R) leads to the emergence of virus displaying high-level resistance to thymidine analogues ([@bib148]; [@bib24]). Dual infection/competition experiments revealed that in the presence of low concentrations of AZT, removal of the two serine residues forming the dipeptide insertion in a multidrug-resistant isolate does not cause a detrimental effect on the replication capacity of the virus ([@bib192]). However, in the absence of drug, the insertions improved the fitness of virus-carrying thymidine analogue mutations (e.g. M41L, L210W, T215Y, etc.). Although, multidrug-resistant mutants are able to maintain high viral loads in the presence of antiretroviral therapy, it should be noted that *in vivo* wild-type HIV variants outcompete those bearing the insertion, as demonstrated when therapy is interrupted ([@bib18]; [@bib140]).

Non-nucleoside RT inhibitors bind to a hydrophobic cavity which is 8--10Å away from the polymerase active site, and lined by the side-chains of Tyr181, Tyr188, Phe227, and Trp229 ([@bib127]). High-level resistance appears quickly after treatment and involves amino acid changes in residues located at the inhibitor binding site ([Table 4.1](#cetable1){ref-type="table"}). Again, resistance mutations often lead to reduced *in vitro* replication capacity. Examples are the nevirapine-resistance mutation V106A and the delavirdine-resistance mutation P236L that impair RNase H activity ([@bib94]; [@bib5]; [@bib63]; [@bib117]; [@bib32]), as well as several mutations at codons 138 and 190, whose effects appear to be related to impaired DNA synthesis and RNase H degradation ([@bib182]; [@bib115]; [@bib32]; [@bib228]).

### HIV-1 Protease (PR) Inhibitors {#cesec14}

The HIV-1 PR is a homodimeric enzyme composed of two polypeptide chains of 99 residues. The substrate binding site is located at the interface between both subunits. The side-chains of Arg8, Leu23, Asp25, Gly27, Ala28, Asp29, Asp30, Val32, Ile47, Gly48, Gly49, Ile50, Phe53, Leu76, Thr80, Pro81, Val82, and Ile84 form the substrate-binding pocket and can interact with specific inhibitors ([@bib239]), such as those used in the clinical treatment of AIDS. Approved PR inhibitors share relatively similar chemical structures and cross-resistance is commonly observed in the clinical setting ([@bib151]). It is not unexpected that many resistance mutations affect residues of the inhibitor-binding pocket of the PR ([Table 4.1](#cetable1){ref-type="table"}). Studies carried out *in vivo* and *in vitro* have shown that several amino acid substitutions involved in drug resistance may have a deleterious effect on viral fitness. Examples are D30N, I47A, I50V, G48V, and V82A ([@bib64]; [@bib145]; [@bib123]; [@bib190]; [@bib245]; [@bib31]).

The deleterious effects caused by drug resistance mutations can be rescued by other amino acid replacements. For example, multidrug-resistant virus arising during prolonged therapy with indinavir contained PR with the substitutions M46I, L63P, V82T, and I84V ([@bib33]; [@bib145]). Crystallographic studies of the mutant enzyme revealed that substitutions at codons 82 and 84 were critical for the acquisition of resistance, while the amino acid changes at codons 46 and 63, which are away from the inhibitor-binding site appear as compensatory mutations ([@bib38]; [@bib208]). Although compensatory mutations within the PR-coding region increase the catalytic efficiency of the enzyme, there are other molecular mechanisms that lead to fitness recovery during PR inhibitor treatments. Examples are: (i) mutations at Gag cleavage sites that increase polyprotein processing ([@bib55]; [@bib248]; [@bib186]), (ii) mutations that affect the frameshift signal between the *gag* and *pol* genes that lead to an increased expression of *pol* products ([@bib56]), or (iii) mutations outside of the cleavage sites that could affect the conformation of the Gag polyprotein and make the cleavage sites more accessible to the viral PR ([@bib91]; [@bib160]).

Novel Antiretroviral Drugs {#cesec15}
--------------------------

For many years, the RT and the PR were the only targets of approved antiretroviral drugs. In 2003, enfuvirtide, a synthetic peptide that impairs virus--host cell membrane fusion, was licensed for clinical use. Resistance to enfuvirtide is mediated by amino acid substitutions at codons 36--38 of the envelope glycoprotein gp41. The amino acid sequences found at those positions in drug-sensitive viruses (DIV, SIV, GIV, or GIM) are replaced by SIM, DIM, or DTV in the drug-resistant clones ([@bib197]). As observed with PR and RT inhibitors, resistance mutations cause a fitness loss, which was estimated to be approximately 10% in replication kinetics and growth competition experiments ([@bib139]; [@bib195]). However, it should be noted that mutations in the V3 loop of the envelope glycoprotein gp120 can also affect the viral susceptibility to enfuvirtide ([@bib194];, and further studies will be necessary to evaluate its impact on viral fitness *in vivo.*

In August 2007, a CCR5 coreceptor antagonist known as maraviroc was approved for clinical use. Maraviroc has potent antiviral activity against CCR5-tropic HIV-1 variants, including primary isolates from various clades ([@bib54]). Maraviroc-resistant HIV variants contained unique amino acid changes in the V3 loop (e.g. A316T and I323V) and other positions within the envelope glycoprotein, gp120, but continued to be phenotypically CCR5-tropic and sensitive to CCR5 antagonists in preclinical development, such as vicriviroc ([@bib231]).

Other antiretroviral drugs showing promising results in clinical trials are the integrase inhibitors raltegravir (licensed in October 2007) and elvitegravir. However, the information available on specific drug resistance mutations and their effects on the viral replication capacity is still preliminary.

This review of fitness effects of drug-resistance mutations in HIV-1 provides a dramatic illustration of the adaptive potential of a viral quasispecies. Acquisition of critical amino acid replacements for drug resistance, fitness effects that favor selection of compensatory mutations either in a viral enzyme or in its target substrate, occurrence of clusters of mutations for multidrug resistance are but some of the mechanisms displayed by HIV-1 to persist in the human population.

OVERVIEW {#cesec16}
========

The virological significance of quasispecies theory becomes more apparent each year. Initial reports of extremely high error rates and great population diversity of RNA viruses were hotly disputed as being incorrect and inconsistent with often-observed stability in virus markers such as antigenicity, disease characteristics, host range, etc. High error rates and intra-population heterogeneity for RNA viruses are now widely accepted. Fortunately, early quasispecies theory presented a timely, remarkably prescient theoretical framework within which the behavior of replicating and evolving RNA virus populations could begin to be understood. Following elaboration by Eigen, Biebricher, Schuster, and colleagues, quasispecies-derived theory has been rapidly progressing and evolving. Its ground-breaking initial theoretical structure for exploring consequences of extreme biological error rates was informed by elegant molecular replication/mutation kinetic studies with small RNA replicons *in vitro.* Original quasispecies theory was formally applicable to these *in vitro* experiments, and was necessarily generalized, idealized, and, in many specifics, openly unrealistic for real viruses. Some simplifying assumptions not applicable to viruses in the real world include: infinite virus populations; global optima in the selective landscape; one most-fit master sequence in a single, unvarying selective landscape; fitness restricted to competition solely between one master sequence and diverse variants of equally low fitness; and, finally, omission of complexities such as replicative interference, lethal mutations, complementation, recombination, etc.

Early modeling could not reasonably encompass all real-life complexities. To attempt inclusion of all would render any model (or alternative collection of models) hopelessly unwieldy, uninformative, and poorly predictive due to requisite alternate weightings of factors. Simplified assumptions not conforming to complex realities need not detract from the ability of models to serve as starting points and guideposts toward new directions for experiment and theory. Quasispecies theory has indisputably led virology to powerful new insights, deductions, and directions. A few critics have suggested that the non-real world parameters in early quasispecies models, and the non-realistic (and foregone) conclusions that can be contrived from them, are reason to reject the general validity and broad significance of quasispecies. Such circular arguments are specious and trivial relative to the experimental and conceptual advances already-made, and yet-to-be-made, via quasispecies theory with its straightforward conclusions and more subtle implications.

Increasingly sensitive analyses of viral quasispecies in recent decades have produced many remarkable insights. The most basic, far-reaching, awesomely predictive tenet of quasispecies theory will never be overshadowed; numerous variant genomes are bound together through extreme mutation rates, forming obligatorily co-selected partnerships in a vast, error-prone mutant spectrum from which they cannot escape, and from which they inevitably and coordinately may exert myriad, changing, ultimately unforseeable effects on all life forms. This tenet has been unquestionably and elegantly confirmed recently by the U. C. San Francisco, Stanford and Penn State groups (as reviewed above and elsewhere in this volume).

A significant postulate of early quasispecies models was that of "error catastrophe." This posits that replicase-generated quasispecies mutation rates are, through evolutionary selection, poised at, or near, an error threshold. Prolonged violation of this threshold (through replicase dysfunction, mutagens, elevated temperatures, nucleotide pool alterations, etc.) leads to virus extinction via a fast and irreversible transition, that has sometimes been equated with a phase transition in physics, as discussed in the opening chapter of this volume. Because the simplified model employed non-realistic parameters and envisioned indefinite mutational drift, critics deny the existence of error thresholds and sharp transitions to error catastrophe. No real-world virus could conform to the simplifying assumptions employed in that model, but recent data from lethal mutagenesis experiments do demonstrate devolution to error catastrophe. Historical precedent for the term "error catastrophe" lies with Orgel\'s suggestion in 1963 of cascading coordinate collapse of cellular information within (and between) various interdependent cellular nucleic acid and protein *trans*-networks. We also employ the term in a broad manner for lethal mutagenesis. This is especially appropriate with mutagens such as 5-FU (which modify both viral and cellular nucleic acids and their encoded functions and structures). We cannot presently rule out some roles for mutagenized cellular, as well as viral, macromolecules, during lethal mutagenesis. Regardless, complex interactions of altered viral macromolecular networks are definitely involved. Extinction is mediated by "*trans*-acting networks" among abundant lethal defector genomes. The senior author\'s group in Madrid demonstrated (reviewed above) that strongly mutagenized RNA virus populations do collapse to extinction via a sharp transition, but without the non-lethal, continuous mutational drift exemplified in the original quasispecies simulations. Extremely rapid extinctions are observed for low-fitness input virus strains, which transition into error catastrophe during a single round of infection/mutagenesis. Lethal mutagenesis of FMDV and LCMV is mediated by full-length, replicating, interfering, lethal defector genomes. Total (defective and viable) genomic RNA mutation frequencies are elevated to varying extents, whereas specific infectivity of total genomic RNA is decreased by several orders of magnitude without any change of RNA consensus sequence. In light of quasispecies "variant-ensemble" behavior, it is not surprising that defective genomes can predominate within *trans*-acting networks during lethal mutagenesis, and continue to replicate even after extinction of LCMV infectivity. Defector *trans*-effects can provide positive complementation in concert with, or alternation with, (orthogonal) interference. Standard concepts of virus fitness are only tangentially applicable within such collapsing *trans*-networks. Catastrophic decay of viral digital information proceeds on (at least) two levels: (1) genetic quenching due to egregious fixation of genomic mutations in a *trans*-network environment that does not always select for optimal function of self-encoded proteins, and (2) phenotypic *trans-*quenching of potentially viable genomes via altered, defector-encoded (interfering) proteins. Possible roles of RNA recombination remain to be explored.

Defector-driven transitions will be challenging to dissect, and no theoretical model can possibly capture even their main intricacies. During lethal mutagenesis at high multiplicities of infection, each infected cell is a single compartment in which a separate, discrete error catastrophe event may devolve. Each discrete *trans*-network is disrupted and obscured during virus passages or RNA transfections following initial infection/mutagenesis. Multiplicity of infection (for both viable and defector virions) is clearly a crucial variable during passages. Virus strains with low replicative fitness (and mutagen-debilitated genomes) theoretically should be (and are) more vulnerable than highly fit strains to defector-mediated error catastrophe. Low-fitness strains cannot quickly produce high yields during temporary escape from defector networks. Future investigations with controlled compartmentalization (e.g. characterization of isolated infectious centers, microinjection of single cells, etc.), together with molecular genetic construction/reconstruction of defined *trans*-networks will illuminate pre-extinction events.

The Madrid group has already verified that ordinary, viable FMDV variant RNAs, and mixtures of variant RNAs bearing defined mutations in the capsid and polymerase genes can exert *trans*-complementation and interference effects on standard FMDV RNA following co-electroporation of cells. Clearly, at high multiplicities of co-electroporation, such mixtures of defined variant and control RNAs generate unique, mutually supportive or suppressive (complementing/interfering) *trans*-acting networks within each individual, coinfected cell. This provides strong analogies to events during the transitions of lethal mutagenesis. The compelling differences, of course, are that the latter devolve to extinction due to: (1) mutagen-elevated mutation, AND elevated mutation-fixation rates in a poorly-selective *trans*-milieu; (2) potent *trans*-quenching of surviving-and-collapsing infectious virus via interfering (lethal defector-encoded) proteins.

Thus, the quasispecies postulate of a rapid transition to extinction has been experimentally verified, albeit the complex defector mechanisms for real viruses differ significantly from those originally modeled, as indeed recognized and anticipated by Eigen (see above). It is evident that the details of lethal mutagenesis will likely differ among families of RNA viruses (e.g. those having mono-, bi-, or multipartitite genomes, strong or weak complementation, homologous or only non-homologous recombination, naked or enveloped capsids, etc.). However, it seems probable that error catastrophe will be observed in all. Although no theoretical model can possibly capture all the ingredients involved in the replicative collapse of a mutagenized viral population, it was the original error threshold which inspired the experiments currently being performed in several laboratories.

The tenets of Eigen, Biebricher, Schuster, and colleagues, derived from first principles and tractable models, have had enormous influence in virology. This pervasive influence is in no manner weakened nor negated by original simplifying assumptions.
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[^1]: For additional information, see ([@bib26]; [@bib30]; [@bib121]).

[^2]: Primary resistance mutations are shown in bold. Most PR inhibitors (saquinavir, indinavir, amprenavir, lopinavir, atazanavir, tipranavir, and darunavir) are usually prescribed in combination with a low dose of ritonavir, that has a boosting effect on the PR inhibitor concentration in plasma.
